1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)-5-iodouracil, 95.0%, 1g

tert-butyl 3-bromo-3-(hydroxymethyl)azetidine-1-carboxylate, 95.0%, 500mg

4-(Benzyloxy)aniline hydrochloride, 95.0%, 500g

Éster metílico del ácido linoleico, mínimo 99 %, 5 ml, envase de vidrio

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(prop-2-yn-1-yl)pentanamide, 95+%, 1g

Methyl 2-(2-bromo-5-chlorophenyl)acetate, 95.0%, 5g

15-Methylhexadecan-1-ol, 95%, 100mg

4-Methoxyindole, 98.0%, 10g

(1R,2R,5S)-3-[(tert-butoxy)carbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 100mg

ALISKIREN, 97%, 10mg

Methyl 2,3-Dihydroxybenzoate>98.0%(GC)25g

methyl 3-(pentylamino)butanoate, 95.0%, 10g

1-(5-Fluoro-2-methyl-3-nitrophenyl)ethanone, 98+%, 25g